Mostrar registro simples

dc.contributor.authorAbu-Raya, Bahaapt_BR
dc.contributor.authorSilva, Denise Rossatopt_BR
dc.contributor.authorEsposito, Susannapt_BR
dc.date.accessioned2021-08-06T04:42:15Zpt_BR
dc.date.issued2020pt_BR
dc.identifier.issn2296-858Xpt_BR
dc.identifier.urihttp://hdl.handle.net/10183/225299pt_BR
dc.description.abstractCoronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofFrontiers in medicine. Lausanne. Vol. 7 (Oct. 2020), 572485, 7 p.pt_BR
dc.rightsOpen Accessen
dc.subjectCoronavirusen
dc.subjectCOVID-19pt_BR
dc.subjectIntensive care managementen
dc.subjectInfecções por coronaviruspt_BR
dc.subjectPreventionen
dc.subjectPrevenção de doençaspt_BR
dc.subjectIsolamento socialpt_BR
dc.subjectWorkplace safetyen
dc.subjectInfection controlen
dc.subjectSARS-CoV-2en
dc.subjectPhysical distancingen
dc.titleCoronavirus disease-19 : an interim evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)pt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001129568pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples